Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1383
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | AKTU | - |
dc.date.accessioned | 2025-10-03T06:23:43Z | - |
dc.date.available | 2025-10-03T06:23:43Z | - |
dc.date.issued | 2024-06 | - |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/1383 | - |
dc.language.iso | en_US | en_US |
dc.subject | BP805ET | en_US |
dc.subject | ADVERSE DRUG REACTION (ADR), ADVERSE EVENT (AE), BENEFIT-RISK MANAGEMENT, CASE MANAGEMENT, SIGNAL DETECTION, DRUG SAFETY, RISK MANAGEMENT, POST-MARKETING SURVEILLANCE, CLINICAL TRIAL SAFETY, MEDICAL DEVICE SAFETY, PHARMACOVIGILANCE OFFICER, AND SAFETY MONITORING | en_US |
dc.title | BP805ET PHARMACOVIGILANCE | en_US |
dc.type | Other | en_US |
Appears in Collections: | 2023-2024 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
BP805ET PHARMACOVIGILANCE.pdf | BP805ET | 121.81 kB | Adobe PDF | Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.